Ubs Global Asset Management Americas »

Lenz Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2025-09-30 $545k 12k 46.58
2025-06-30 $737k 25k 29.31